Seeking Alpha

PainReform Files Patent Covering Highly Scalable Manufacturing Process for PRF-110 Following Successful Completion and Testing

Continuous Process Manufacturing: Streamlining production to ensure constant and efficient output, thereby significantly reducing downtime and increasing overall productivity. Single Reactor ...
Seeking Alpha

PainReform’s New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature

TEL AVIV, Israel, Aug. 01, 2024 (GLOBE NEWSWIRE) -- PainReform (PRFX) Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the ...
C&EN

Comment: Celebrating 80 years of the Petroleum Research Fund—a legacy of fundamental hydrocarbon research

The Petroleum Research Fund (PRF) trust agreement celebrates its 80th anniversary this year, commemorating 7 decades of steadfast financial support for researchers. Established in 1944, the PRF has ...
Nature

Regenerative Medicine Using Platelet-Rich Fibrin and Growth Factors

Regenerative medicine has experienced a paradigm shift with the advent of platelet‐rich fibrin (PRF) and its integration with growth factors. PRF, an autologous concentrate derived from blood, ...
Business Insider

PainReform Files Patent Covering Highly Scalable Manufacturing Process for PRF-110 Following Successful Completion and Testing

TEL AVIV, Israel, July 24, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of ...